Medical specialists from Canada tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Total 40 results

Ali A. El-Gayed
Seen in:
- Saskatchewan, Saskatoon, Saskatoon Cancer Centre
Trials:
- NCT01810913 (Principal Investigator)
- NCT04852887 (Principal Investigator)
- NCT05050084 (Principal Investigator)
Conditions:
Amit Oza
Seen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
- Toronto, Princess Margaret Cancer Center
- Toronto, Princess Margaret Cancer Centre
Trials:
- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04159155 (Principal Investigator)
- NCT02334761 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:
Anand Swaminath, MD
Seen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:
- NCT04435938 (Sub-Investigator)
Conditions:
Anna Spreafico
Seen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
- Other, Toronto, University Health Network, Princess Margaret Hospital
- Toronto, University Health Network, Princess Margaret Hospital
Trials:
- NCT03816345 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:
Arif Awan
Seen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, University of Ottawa / Ottawa General Hospital
Trials:
- NCT05571839 (Principal Investigator)
- NCT04609566 (Principal Investigator)
- NCT05194072 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT05229900 (Principal Investigator)
Conditions:
Ayesha Bashir
Seen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:
- NCT05050162 (Principal Investigator)
Conditions:
Baskoro Kartolo
Seen in:
- Ontario, Hamilton, GSK Investigational Site
Trials:
- NCT06256588 (Principal Investigator)
Conditions:
- Neoplasms, Head and Neck
Brock Debenham, MD
Seen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:
- NCT03546582 (Principal Investigator)
Conditions:
- Head and Neck Squamous Cell Carcinoma (HNSCC)
Brock J. Debenham
Seen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:
- NCT01810913 (Principal Investigator)
Conditions:
Daniel Juneau, MD
Seen in:
- Quebec, Montréal, CHUM
Trials:
- NCT06147037 (Principal Investigator)
Conditions:
Derek Jonker
Seen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, Ottawa Hospital Cancer Centre (OHRI)
Trials:
- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:
Diane Provencher
Seen in:
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal (CHUM)
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal
Trials:
- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:
Enrique Sanz García
Seen in:
- Ontario, Toronto, GSK Investigational Site
Trials:
- NCT06062420 (Principal Investigator)
Conditions:
- Neoplasms, Head and Neck
Éric Turcotte, MD
Seen in:
- Quebec, Sherbrooke, CIUSSS de l'Estrie - CHUS
Trials:
- NCT06147037 (Sub-Investigator)
Conditions:
George Shenouda
Seen in:
- Quebec, Montreal, McGill University Department of Oncology
- Quebec, Montreal, The Research Institute of the McGill University Health Centre (MUHC)
- Quebec, Montréal, McGill University
Trials:
- NCT02135042 (Principal Investigator)
- NCT05050162 (Principal Investigator)
- NCT03546582 (Principal Investigator)
Conditions:
Jennifer Spratlin
Seen in:
- Alberta, Edmonton, GSK Investigational Site
- Alberta, Edmonton, University of Alberta / Cross Cancer Institute
Trials:
- NCT04254107 (Principal Investigator)
- NCT05855200 (Principal Investigator)
Conditions:
John J Kim, MD
Seen in:
- Ontario, Toronto, University Health Network, Princess Margaret Cancer Center
Trials:
- NCT02678884 (Principal Investigator)
Conditions:
- Head and Neck Squamous Cell Carcinoma
John N. Waldron
Seen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:
- NCT03952585 (Principal Investigator)
Conditions:
John R. de Almeida
Seen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:
- NCT04333537 (Principal Investigator)
Conditions:
Joshua Giambattista
Seen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:
- NCT01810913 (Principal Investigator)
Conditions:
Kamal-Uddin Haider
Seen in:
- Saskatchewan, Saskatoon, Saskatoon Cancer Centre
Trials:
- NCT05050162 (Principal Investigator)
Conditions:
Kerry Courneya
Seen in:
- Alberta, Edmonton, University of Alberta
Trials:
- NCT06289049 (Principal Investigator)
Conditions:
Khashayar Esfahani
Seen in:
- Quebec, Montreal, GSK Investigational Site
Trials:
- NCT06062420 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:
- Neoplasms, Head and Neck
Lillian L. Siu
Seen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:
- NCT05172245 (Principal Investigator)
Conditions:
Lillian Siu
Seen in:
- Ontario, Toronto, GSK Investigational Site
- Other, Toronto, University Health Network, Princess Margaret Hospital
Trials:
- NCT04446351 (Principal Investigator)
- NCT04254107 (Principal Investigator)
- NCT05277051 (Principal Investigator)
Conditions:
Lucy Gilbert
Seen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:
- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:
Marc Webster
Seen in:
- Alberta, Calgary, GSK Investigational Site
- Alberta, Calgary, Tom Baker Cancer Center
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:
- NCT05514054 (Principal Investigator)
- NCT02135042 (Principal Investigator)
- NCT06062420 (Principal Investigator)
Conditions:
Martin Smoragiewicz
Seen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, Sunnybrook Health Sciences Centre
- Ontario, Toronto, Sunnybrook Research Institute
Trials:
- NCT05288166 (Principal Investigator)
- NCT06062420 (Principal Investigator)
Conditions:

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Washington University School of Medicine
Merck Sharp & Dohme LLC

Active, not recruiting

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Carcinoma, Squamous Cell of Head and Neck | Neoplasms, Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States
Washington University School of Medicine
Celgene Corporation

Active, not recruiting

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (APA)

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and Neck

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Recruiting

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Recurrent Head and Neck Squamous Cell Carcinoma | Advanced Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Locally Advanced Head and Neck Squamous Cell Carcinoma | Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage IV Cutaneous...

United States
University of Pittsburgh
National Cancer Institute (NCI)

Terminated

Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck

United States
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
National Cancer Institute (NCI)

Not yet recruiting

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Stage II Squamous Cell Carcinoma of the Head and Neck | Stage III Squamous Cell Carcinoma of the Head and Neck | Stage IV Squamous Cell Carcinoma of the Head and Neck

United States
Eben Rosenthal
National Cancer Institute (NCI)

Completed

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck (SCCHN)

United States
Washington University School of Medicine

Active, not recruiting

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States
Arnaud Bewley, MD
National Cancer Institute (NCI); Genentech, Inc.

Terminated

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck

United States
James J Lee
AVEO Pharmaceuticals, Inc.

Completed

Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck

United States

Medical specialists from Canada tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations